Skip to content

Clinical trials

Phase 3 Graft vs Host Disease trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Phase: Phase 3 Country / region: France Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20161
20175
20181
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
Incyte Corporation2
Novartis Pharmaceuticals2
Adienne SA1
Equillium1
European Society for Blood and Marrow Transplantation1
Kiadis Pharma1
Pharmacyclics LLC.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease11
Bronchiolitis Obliterans Syndrome2
Hematologic Neoplasms1
Immune System Diseases1
Leukemia, Myeloid, Acute1
Myelodysplastic Syndromes1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.